GlassScriptPhysician profile
Scott L Palmer
NPI 1598776668
$2,823.12
in general payments reported to CMS, 2019-2025
23 companies · $201 in 2025
The $201 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,791 · 2020: $13.60 · 2021: $17.50 · 2022: $168 · 2023: $329 · 2024: $302 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $832.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $832.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,672.97 | 2019 | |
| Sumitomo Pharma America, INC. | $305.47 | 2023-2024 | Gemtesa |
| Boston Scientific Corporation | $141.06 | 2022-2025 | Axonics, General - Bph |
| Abbvie INC. | $112.86 | 2019-2025 | |
| Pfizer INC. | $64.19 | 2022-2023 | |
| 180 Medical, INC. | $55.69 | 2025 | |
| Laborie Medical Technologies Corp. | $55.27 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Merck Sharp & Dohme LLC | $48.98 | 2023-2024 | Keytruda, Welireg, Lynparza |
| Teleflex LLC | $48.63 | 2021-2025 | Urolift |
| Axonics, INC. | $36.02 | 2023 | Bulkamid, Axonics |
| Edap Technomed INC | $33.00 | 2024 | |
| Janssen Biotech, INC. | $32.20 | 2022-2023 | Erleada |
| Astellas Pharma US INC | $30.41 | 2019-2020 | |
| Blue Earth Diagnostics | $28.31 | 2019 | |
| Endo USA, INC. | $23.69 | 2024 | Aveed, Xiaflex |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Travere Therapeutics, INC. | $23.05 | 2019 | |
| Dendreon Pharmaceuticals LLC | $18.27 | 2019 | |
| Abc Home Medical Supply, INC. | $17.63 | 2025 | |
| Zyla Life Sciences, INC. | $17.62 | 2019 | |
| Urovant Sciences INC | $16.43 | 2022 | |
| Ambu INC. | $14.68 | 2022 | |
| Antares Pharma, INC. | $14.28 | 2022 | |
| Calyxo, INC. | $12.41 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Palmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.